Abstract
Weber LJ, Wayland MT, Holton B. Health care professionals and industry: reducing conflicts
of interest and established best practices. Arch Phys Med Rehabil 2001;82 Suppl 2:S20-4.
The relationship between health care providers and pharmaceutical companies and other
commercial interests is ethically complex. The common practice of IMAGEt giving takes
many forms including free samples, sponsorship of medical education, loan of equipment,
and IMAGEts ranging from those of nominal value such as pens to more valuable IMAGEts
such as golf outings or dinners. IMAGEt giving is a practice that serves both the
recipient and the giver, but, in the medical setting, it raises the question of whether
this is to the detriment of patient care. Although health care professionals may believe
they are able to ignore influence from commercial interests, human judgment research
indicates that decision-makers are generally unaware of biases affecting their decisions.
This is an issue of organizational ethics as well. Institutions that allow commercial
interests to give some form of IMAGEt are allowing the appearance of bias as well
as placing the burden of avoiding bias on the individual rather than on the institution.
Conflict-of-interest analysis indicates that best practice is to limit or eliminate
the influence of commercial interests, ensuring that professionals are better able
to exercise their independent objective judgment. © by the American Congress of Rehabilitation
Medicine
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Archives of Physical Medicine and RehabilitationAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
References
- Physicians and the pharmaceutical industry: is a IMAGEt ever just a IMAGEt?.JAMA. 2000; 283: 373-380
- Growing opposition to free drug samples.The New York Times. 2000 Nov 15; (Sect C1 (col 2))
- The pharmaceutical industry-to whom is it accountable?.N Engl J Med. 2000; 342 ([editorial]): 1902-1904
- Separating continuing medical education from pharmaceutical marketing.JAMA. 2001; 285: 2009-2012
- Is academic medicine for sale?.N Engl J Med. 2000; 342 ([editorial]): 1516-1518
- Scientific community begins to fight back for integrity against for-profit research.Ethics-In-Formation. 2000; 9: 8
- Uneasy alliance-clinical investigators and the pharmaceutical industry.N Engl J Med. 2000; 342: 1539-1544
- Human inference: strategies and shortcomings of social judgement.Prentice Hall, Englewood (NJ)1980
- Code of medical ethics: current opinions of the Council on Ethical and Judicial Affairs.AMA, Chicago (IL)1998-99
- The psychosocial impact of rehabilitation technology.Phys Med Rehabil State Art Rev. 1997; 11: 239-252
- Business ethics in healthcare: beyond compliance.Indiana Univ Pr, Bloomington (IN)2001
- Policy statement on industry supported scientific and educational activities.(62 Federal Register 64073)1997
- The ACCME's essential areas and their elements.http://www.accme.org/sec_docs_f.asp(Available at Accessed)Date: October 2, 2001
Article info
Publication history
Accepted:
November 5,
2001
0003-9993/01/8212-7195$35.00/0 No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated.Identification
Copyright
© 2001 Published by Elsevier Inc.